Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 37 OTHER 17 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 90 Vincristine 83 Doxorubicin 69 Prednisone 66 Cytarabine 59 Methotrexate 58 Rituximab 49 Etoposide 43 Radiotherapy 41 Dexamethasone 41 Filgrastim 39 Leucovorin 27 Mercaptopurine 26 Granulocyte Colony-Stimulating Factor 26 pegaspargase 22 Calcium Dobesilate 22 Daunorubicin 21 Asparaginase 20 merphos 19 Specimen Handling 18 Thioguanine 17 Hydrocortisone 16 Bleomycin 16 Peripheral Blood Stem Cell Transplantation 14 Vinblastine 13 Gene Expression Profiling 13 Methylprednisolone 12 Ifosfamide 12 Gemcitabine 12 dexamethasone acetate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × idelalisib × Lymphoid × Clear all

NCT03576443 2021-10-13

ILIAD

Nordic Lymphoma Group

Phase 2 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡